"The Taustine Eye Center is Louisville’s leading eye surgery, research and care practice. Created over 30 years ago by Dr. Lloyd Taustine, we have been the first practice in the area to adopt many new procedures for advanced diagnosis and treatment of eye diseases and disorders. Today, we offer the most up-to-date technologies available for cataracts, diabetic retinopathy, glaucoma, LASIK and macular degeneration. As we look to the future, one thing will remain the same, our commitment to personal care, honesty and integrity. You can be assured that when you walk through our doors you will receive the best care available."

During the past decade, Taustine Eye Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taustine Eye Center" #1 sponsor was "Aerie Pharmaceuticals" with 7 trials, followed by "Allergan" with 2 trials sponsored, "Kala Pharmaceuticals, Inc." with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taustine Eye Center" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Taustine Eye Center" are "Ocular Hypertension" (5 trials), "Glaucoma" (3 trials), "Keratoconjunctivitis Sicca" (3 trials), "Open Angle Glaucoma" (3 trials) and "Dry Eye Syndromes" (2 trials). Many other conditions were trialed in "Taustine Eye Center" in a lesser frequency.

Most popular intervention types in "Taustine Eye Center" are "Drug" (17 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AR-12286 Ophthalmic Solution 0.5%" (2 trials), "Latanoprost 0.005%" (2 trials), "Placebo" (2 trials), "Vehicle" (2 trials) and "AGN-195263" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taustine Eye Center" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Taustine Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Taustine Eye Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Taustine Eye Center, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".